开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Teo James
Heat shock proteins (HSPs) were discovered in the early 1960s as important intracellular proteinaceous components that aid in stress physiology and reprogram cellular responses to allow the organism to survive. HSPs were discovered in extracellular spaces in the early 1990s and were shown to activate gamma-delta T-lymphocytes. Subsequent research linked them to a variety of diseases, including autoimmune disorders, diabetes, cancer, hepatic, pancreatic, and renal illnesses, and cachexia. In recent years, there has been a lot of excitement and enthusiasm surrounding the idea of HSP-targeted new molecular therapies.